Each year, PDL reviews data reported by members, and reflects on the challenges pharmacists have faced, while extracting insights from the patterns/trends that emerged.
Below are the top 10 most reported medicines in the 2024-2025 financial year:
Oxycodone (immediate and slow release, individually and in combination)
Semaglutide
Tapentadol
Methylphenidate
Prednisone/olone
Tirzepatide
Oestrogen (oral and patches, individually and in combination but excludes oral contraceptives)
Lisdexamfetamine
Paracetamol and codeine combinations
Levothyroxine
The PDL Prof…
